170 related articles for article (PubMed ID: 8031750)
1. Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism.
Janakiraman MN; White CL; Laver WG; Air GM; Luo M
Biochemistry; 1994 Jul; 33(27):8172-9. PubMed ID: 8031750
[TBL] [Abstract][Full Text] [Related]
2. Influenza B virus neuraminidase can synthesize its own inhibitor.
Burmeister WP; Henrissat B; Bosso C; Cusack S; Ruigrok RW
Structure; 1993 Sep; 1(1):19-26. PubMed ID: 8069621
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
[TBL] [Abstract][Full Text] [Related]
4. Structures of aromatic inhibitors of influenza virus neuraminidase.
Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
[TBL] [Abstract][Full Text] [Related]
5. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.
Burmeister WP; Ruigrok RW; Cusack S
EMBO J; 1992 Jan; 11(1):49-56. PubMed ID: 1740114
[TBL] [Abstract][Full Text] [Related]
6. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
[TBL] [Abstract][Full Text] [Related]
7. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
[TBL] [Abstract][Full Text] [Related]
8. Analysis of inhibitor binding in influenza virus neuraminidase.
Smith BJ; Colman PM; Von Itzstein M; Danylec B; Varghese JN
Protein Sci; 2001 Apr; 10(4):689-96. PubMed ID: 11274459
[TBL] [Abstract][Full Text] [Related]
9. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase.
Lommer BS; Ali SM; Bajpai SN; Brouillette WJ; Air GM; Luo M
Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1017-23. PubMed ID: 15159560
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis.
Taylor NR; von Itzstein M
J Med Chem; 1994 Mar; 37(5):616-24. PubMed ID: 8126701
[TBL] [Abstract][Full Text] [Related]
11. A single sequence change destabilizes the influenza virus neuraminidase tetramer.
Colacino JM; Chirgadze NY; Garman E; Murti KG; Loncharich RJ; Baxter AJ; Staschke KA; Laver WG
Virology; 1997 Sep; 236(1):66-75. PubMed ID: 9299618
[TBL] [Abstract][Full Text] [Related]
12. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
Wei DQ; Du QS; Sun H; Chou KC
Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045
[TBL] [Abstract][Full Text] [Related]
13. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.
Varghese JN; McKimm-Breschkin JL; Caldwell JB; Kortt AA; Colman PM
Proteins; 1992 Nov; 14(3):327-32. PubMed ID: 1438172
[TBL] [Abstract][Full Text] [Related]
14. The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution.
Crennell SJ; Garman EF; Philippon C; Vasella A; Laver WG; Vimr ER; Taylor GL
J Mol Biol; 1996 Jun; 259(2):264-80. PubMed ID: 8656428
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.
Crennell SJ; Garman EF; Laver WG; Vimr ER; Taylor GL
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9852-6. PubMed ID: 8234325
[TBL] [Abstract][Full Text] [Related]
16. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
[TBL] [Abstract][Full Text] [Related]
17. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
[TBL] [Abstract][Full Text] [Related]
18. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction.
Singh S; Jedrzejas MJ; Air GM; Luo M; Laver WG; Brouillette WJ
J Med Chem; 1995 Aug; 38(17):3217-25. PubMed ID: 7650674
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position.
Holzer CT; von Itzstein M; Jin B; Pegg MS; Stewart WP; Wu WY
Glycoconj J; 1993 Feb; 10(1):40-4. PubMed ID: 8358225
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.
Varghese JN; Epa VC; Colman PM
Protein Sci; 1995 Jun; 4(6):1081-7. PubMed ID: 7549872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
